Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-06-17

European cell therapy in the nervous system

Objective

Ectins will find commercially viable ways to derive conditionally immortalised neural stem cells, identify their key phenotype features, patterns of gene expression and biological activities that predict in vivo efficacy. We shall demonstrate clinical potential, study dosing and cell placement through developing predictive animal models of human neurological disease states. Media formulations will be optimised for long term viability, maintain efficacious properties and minimise toxicity. We shall develop non-invasive magnetic resonance imaging methods to follow the activity of grafted cells in human stroke patients. Scientific innovation at all stages of the programme will ensure future product pipelines.

Call for proposal

Data not available

Coordinator

RENEURON LIMITED
EU contribution
No data
Address
5-11 LAVINGTON STREET
SE1 0NZ LONDON
United Kingdom

See on map

Total cost
No data

Participants (8)